Ginès, Pere.
Pere Ginès researcher
Ginès i Gibert, Pere
VIAF ID: 86958196 (Personal)
Permalink: http://viaf.org/viaf/86958196
Preferred Forms
-
-
100 1 _ ‡a Ginès, Pere
-
100 1 _ ‡a Ginès, Pere
-
-
100 1 _ ‡a Ginès, Pere
-
-
100 1 _ ‡a Ginès i Gibert, Pere
-
-
100 1 _ ‡a Ginès, Pere
-
-
-
-
100 0 _ ‡a Pere Ginès ‡c researcher
4xx's: Alternate Name Forms (8)
Works
Title | Sources |
---|---|
Ascites and renal dysfunction in liver disease : pathogenesis, diagnosis, and treatment |
![]() ![]() ![]() ![]() |
Autotest: gastroenterología y hepatología |
![]() ![]() |
Avaluació d'un programa d'infermeria d'atenció immediata a persones amb problemes de salut aguts lleus |
![]() |
Chronic liver failure mechanisms and management |
![]() ![]() |
Cirrosi hepàtica descompensada : impacte global de la síndrome de insuficiència hepàtica aguda sobre crònica i avaluació d’un nou biomarcador pronòstic |
![]() |
Contribució a l'estudi de la hiponatrèmia a la cirrosi hepàtica : descripció d'una nova causa i implicacions sobre la qualitat de vida dels pacients |
![]() |
Efecte de l'administració de seroalbúmina en el deteriorament de la funció renal i la mortalitat dels pacients amb peritonitis bacteriana espontània |
![]() |
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium |
![]() |
Estudio de los microRNAs en la fisiopatología de la hepatitis alcohólica |
![]() |
Expresión Génica Hepática en pacientes con hepatopatías crónicas : identificacación de dianas terapéuticas y evaluación de un tratamiento antifibrogénico |
![]() |
Generació de cèl·lules estrellades derivades de iPSCs i la seva utilització com a model per l'estudi de la fibrosi hepàtica |
![]() |
Hepatitis alcohólica : estratificación pronóstica e identificación de mecanismos patogénicos |
![]() |
Insuficiencia renal en la cirrosis evaluación de nuevas clasificaciones pronósticas y tratamiento del síndrome hepato-renal tipo 1 asociado a sepsis |
![]() |
Investigació de les bases cel·lulars i moleculars de la fibrosi hepàtica : paper dels sistemes vasoactius |
![]() |
Investigación de la función contráctil de las células estrelladas hepáticas: regulación por vasoconstrictores |
![]() |
Investigación del papel de la hiponatremia como factor de riesgo de encefalopatía hepática en la cirrosis |
![]() |
A new scoring system for prognostic stratification of patients with alcoholic hepatitis |
![]() |
[New therapeutic strategies in liver fibrosis: pathogenic basis] |
![]() |
Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. |
![]() |
Official congress report Autoimmune diseases of the liver Falk Symposium 197, Lisbon, May 8-9, 2015 |
![]() |
[Pancreatic ascites. Study of 3 cases and review of the literature] |
![]() |
La paracentesi en el tractament dels malalts cirròtics amb ascites |
![]() ![]() ![]() |
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy. |
![]() |
Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury. |
![]() |
Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis |
![]() |
[Physiopathology of ascites in cirrhosis. A multidisciplinary problem] |
![]() |
Portal hypertension |
![]() |
Postępy w chorobach wewnętrznych / Christian Mueller [i inni] // MP Medycyna Praktyczna. - 10 (368) 2021, strony 8-18. |
![]() |
Postępy w chorobach wewnętrznych - najważniejsze dokonania ostatnich lat : opinie ekspertów MIRCIM. |
![]() |
Practical recommendations for the treatment of ascites and its complications |
![]() |
PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology |
![]() |
Predicting mortality in cirrhosis--serum sodium helps |
![]() |
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study |
![]() |
Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA |
![]() |
Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study |
![]() |
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis |
![]() |
Prognostic significance of renal dysfunction in cirrhosis. |
![]() |
Prognostic value and treatment of hyponatremia in patients with advanced cirrhosis and acute on chronic liver failure |
![]() ![]() |
Refractory ascites: definition and mechanism |
![]() |
Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. |
![]() |
Renal effects of amino acid administration in cirrhosis |
![]() |
Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis |
![]() |
Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis |
![]() |
Reply to: "Acute-on-chronic liver failure - its definition remains unclear". |
![]() |
Reply to: "To close the stable door before the horse has bolted". |
![]() |
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. |
![]() |
Review article: albumin for circulatory support in patients with cirrhosis. |
![]() |
[Role of albumin in the treatment of hepatorenal syndrome in cirrhosis] |
![]() |
Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development. |
![]() |
Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients. |
![]() |
Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. |
![]() |
Therapy in liver diseases |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial |
![]() |
Therapy with vasoconstrictor drugs in cirrhosis: The time has arrived |
![]() |
[Thrombocytopenic purpura and acute nephropathy associated with circulating immune complexes in hepatitis A virus infection] |
![]() |
TIPS and refractory ascites. Lessons from the recent history of ascites therapy |
![]() |
Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study |
![]() |
Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis |
![]() |
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems |
![]() |
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis |
![]() ![]() |
Trastorn circulatori postparacentesi. Incidència, implicacions pronòstiques i prevenció amb expansors plasmàtics |
![]() |
Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. |
![]() |
Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats |
![]() |
Urinary excretion of 6-keto-prostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites |
![]() |
Urinary excretion of endogenous digitalis-like natriuretic substances in healthy subjects. Effect of sodium load. |
![]() |
Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections. |
![]() |
Utilidad del MELD y el sodio pretrasplante en el pronóstico del trasplante hepático a corto plazo |
![]() |
Valoración de la Función Ventricular Izquierda en la Cirrosis Hepática: Relación con la Hemodinámica Sistémica y la Disfunción Renal |
![]() |
Vaptans: a promising therapy in the management of advanced cirrhosis. |
![]() |
Vasopressin in pathophysiological states. |
![]() |
What's new in the treatment of ascites and spontaneous bacterial peritonitis. |
![]() |